Neurodegeneration in the cortical sulcus is a feature of chronic traumatic encephalopathy and associated with repetitive head impacts
- PMID: 39643767
- PMCID: PMC11624223
- DOI: 10.1007/s00401-024-02833-8
Neurodegeneration in the cortical sulcus is a feature of chronic traumatic encephalopathy and associated with repetitive head impacts
Abstract
Neurodegeneration is a seminal feature of many neurological disorders. Chronic traumatic encephalopathy (CTE) is caused by repetitive head impacts (RHI) and is characterized by sulcal tau pathology. However, quantitative assessments of regional neurodegeneration in CTE have not been described. In this study, we quantified three key neurodegenerative measures, including cortical thickness, neuronal density, and synaptic proteins, in contact sport athletes (n = 185) and non-athlete controls (n = 52) within the sulcal depth, middle, and gyral crest of the dorsolateral frontal cortex. Cortical thickness and neuronal density were decreased within the sulcus in CTE compared to controls (p's < 0.05). Measurements of synaptic proteins within the gyral crest showed a reduction of α-synuclein with CTE stage (p = 0.002) and variable changes in PSD-95 density. After adjusting for age, multiple linear regression models demonstrated a strong association between the duration of contact sports play and cortical thinning (p = 0.001) and neuronal loss (p = 0.032) within the sulcus. Additional regression models, adjusted for tau pathology, suggest that within the sulcus, the duration of play was associated with neuronal loss predominantly through tau pathology. In contrast, the association of duration of play with cortical thinning was minimally impacted by tau pathology. Overall, CTE is associated with cortical atrophy and a predominant sulcal neurodegeneration. Furthermore, the duration of contact sports play is associated with measures of neurodegeneration that are more severe in the cortical sulcus and may occur through tau-dependent and independent mechanisms.
Keywords: Chronic traumatic encephalopathy; Contact sports; Cortical sulcus; Cortical thinning; Neurodegeneration; Neuronal loss; Repetitive head impacts; Synaptic loss; Tau pathology.
© 2024. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply.
Conflict of interest statement
Declarations. Conflict of interest: Outside of the submitted work, WX received research support from the National Institutes of Health, Veterans Health Administration, Biomedical Laboratory Research and Development, and Veterans Health Administration, Clinical Sciences Research and Development Merit Awards. He reports being principal investigator and co-investigator on clinical trials, and has a patent pending regarding the diagnosis of AD using machine learning. JDC received grant support from the Department of Veterans Affairs Career Development Award and National Institute of Aging Boston University AD Center. YT reports receiving grant support to the Boston University School of Public Health. ACM reports grant support for other works from the NINDS/NIA, NIA, and VA, and honoraria from the University of Massachusetts, Montefiore Medical Center, Korean Dementia Society, and Texas Neurological Society. The remaining authors report no relevant conflicts of interest.
Figures
References
Publication types
MeSH terms
Substances
Grants and funding
- RF1 AG057768/AG/NIA NIH HHS/United States
- F31NS127449/NS/NINDS NIH HHS/United States
- I01BX005161/U.S. Department of Veterans Affairs
- U01 NS086659/NS/NINDS NIH HHS/United States
- U54 NS115266/NS/NINDS NIH HHS/United States
- U19AG068753/AG/NIA NIH HHS/United States
- PRARP #13267017/Peer Reviewed Alzheimer's Research Program
- HHSN268201500011C/HL/NHLBI NIH HHS/United States
- 75N92019D00031/HL/NHLBI NIH HHS/United States
- R56 AG057768/AG/NIA NIH HHS/United States
- U19 AG068753/AG/NIA NIH HHS/United States
- RF1 AG054156/AG/NIA NIH HHS/United States
- RF1AG057768/AG/NIA NIH HHS/United States
- R01 AG054076/AG/NIA NIH HHS/United States
- K23AG046377/AG/NIA NIH HHS/United States
- RF1AG054156/AG/NIA NIH HHS/United States
- U01NS086659/NS/NINDS NIH HHS/United States
- HHSN268201500001C/HL/NHLBI NIH HHS/United States
- U54NS115266/NS/NINDS NIH HHS/United States
- P30 AG013846/AG/NIA NIH HHS/United States
- P30 AG072978/AG/NIA NIH HHS/United States
- I01BX005933/U.S. Department of Veterans Affairs
- HHSN268201000011C/HL/NHLBI NIH HHS/United States
- K23 NS102399/NS/NINDS NIH HHS/United States
- R56AG057768/AG/NIA NIH HHS/United States
- I01 BX005161/BX/BLRD VA/United States
- P30AG13846/National Institute of Aging Boston University AD Center
- F31 NS127449/NS/NINDS NIH HHS/United States
- R01 AG008122/AG/NIA NIH HHS/United States
- HHSN2682015000011/HL/NHLBI NIH HHS/United States
- HHSN268201500001I/HL/NHLBI NIH HHS/United States
- I01 CX001038/CX/CSRD VA/United States
- NIRG-362697/ALZ/Alzheimer's Association/United States
- AG08122/National Institute of Aging
- K23 AG046377/AG/NIA NIH HHS/United States
- K23NS102399/NS/NINDS NIH HHS/United States
- NIRG-305779/ALZ/Alzheimer's Association/United States
- AG054076/AG/NIA NIH HHS/United States
LinkOut - more resources
Full Text Sources
